Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127043321 | 12704332 | 1 | I | 20160826 | 20160831 | 20160831 | PER | US-PFIZER INC-2016408552 | PFIZER | 69.00 | YR | F | Y | 100.00000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127043321 | 12704332 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY | Y | 20235 | 300 | MG | CAPSULE, HARD | TID | |||||
| 127043321 | 12704332 | 2 | C | MELOXICAM. | MELOXICAM | 1 | Oral | 7.5 MG, 2X/DAY, ONE EVERY 12 HOURS | 0 | 7.5 | MG | BID | |||||||
| 127043321 | 12704332 | 3 | C | MELOXICAM. | MELOXICAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127043321 | 12704332 | 1 | Neuralgia |
| 127043321 | 12704332 | 2 | Inflammation |
| 127043321 | 12704332 | 3 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127043321 | 12704332 | Erythema | |
| 127043321 | 12704332 | Off label use | |
| 127043321 | 12704332 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |